Oncorus Valuation
| ONCRDelisted Stock | USD 0.04 0.01 14.71% |
Oncorus seems to be overvalued based on Macroaxis valuation methodology. Our model determines the value of Oncorus from analyzing the company fundamentals such as Return On Equity of -1.25, shares outstanding of 26.09 M, and Shares Owned By Institutions of 55.29 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Oncorus' price fluctuation is very steady at this time. Calculation of the real value of Oncorus is based on 3 months time horizon. Increasing Oncorus' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Oncorus stock is determined by what a typical buyer is willing to pay for full or partial control of Oncorus. Since Oncorus is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Oncorus Stock. However, Oncorus' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0435 | Real 0.0413 | Hype 0.0435 | Naive 0.0904 |
The intrinsic value of Oncorus' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Oncorus' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Oncorus helps investors to forecast how Oncorus stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Oncorus more accurately as focusing exclusively on Oncorus' fundamentals will not take into account other important factors: Oncorus Total Value Analysis
Oncorus is now forecasted to have valuation of 25.71 M with market capitalization of 3.15 M, debt of 70.65 M, and cash on hands of 100.24 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Oncorus fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
25.71 M | 3.15 M | 70.65 M | 100.24 M |
Oncorus Asset Utilization
One of the ways to look at asset utilization of Oncorus is to check how much profit was generated for every dollar of assets it reports. Oncorus holds a negative application of assets of -0.32 pct., losing $0.003224 for each dollar of assets held by the company. Inadequate asset utilization implies the company is being less effective with each dollar of assets it holds. Put it differently, asset utilization of Oncorus shows how discouraging it operates for each dollar spent on its assets.Oncorus Ownership Allocation
Oncorus owns a total of 26.09 Million outstanding shares. Over half of Oncorus' outstanding shares are owned by third-party entities. These third-party entities are typically referred to as corporate investors that secure positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.Oncorus Profitability Analysis
Net Loss for the year was (77.42 M) with profit before overhead, payroll, taxes, and interest of 0.About Oncorus Valuation
The delisted stock valuation mechanism determines Oncorus' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Oncorus based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Oncorus. We calculate exposure to Oncorus's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Oncorus's related companies.Oncorus, Inc., a clinical-stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients. Oncorus, Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts. Oncorus operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 82 people.
Oncorus Growth Indicators
Investing in growth stocks can be very risky. If the company such as Oncorus does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 25.9 M |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Consideration for investing in Oncorus Stock
If you are still planning to invest in Oncorus check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Oncorus' history and understand the potential risks before investing.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Transaction History View history of all your transactions and understand their impact on performance |